Login / Signup

Safety and Efficacy of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: A Prospective, Multicenter, Observational Study.

Li YingJi SuyunLiang YanhuaLiang YunshengDeng LiDang LinLv ChengzhiLin BingjiangZhang FurenShi WendiLi JinnanDong YuDou GuanshenYu-Ling Shi
Published in: Advances in therapy (2023)
Ixekizumab was well tolerated and effective in real-world clinical practice in Chinese adults with moderate-to-severe plaque psoriasis.
Keyphrases
  • clinical practice
  • coronary artery disease
  • high intensity
  • early onset
  • cross sectional
  • atopic dermatitis
  • drug induced